French squeeze on generics adds to industry's woes
This article was originally published in Scrip
The French health ministry has announced that the pharmaceutical industry will be called on to make a further contribution of €290 million in 2012 as a result of the cut in the annual target rate for growth in healthcare expenditure over the next few years.
You may also be interested in...
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.
A number of countries are resorting to extreme measures such as export bans to preserve stocks of medicines for the COVID-19 pandemic. Belgium is among the latest to impose an export prohibition, but might it fall foul of the EU’s export regulations?
In addition to our daily in-depth coverage of key events relating to the COVID-19 pandemic, we’re bringing you a periodic round-up of other developments. This edition covers Europe and other countries.